AnalystBook Research · Company Intelligence

CPS TECHNOLOGIES CORP/DE/

CPSHNasdaq

Built from CPS TECHNOLOGIES CORP/DE/'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue increased 54.3% to $32.6M, while Net income increased 113.4% to $420.4K.

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue $32.6MOK
  • ProfitabilityNet income $420.4KOK
  • Cash generationFree cash flow ($487.0K)Note
  • AccountingDistress-safe · manipulation screen not computed · earnings quality safeNote
  • Insiders9 buys; 0 sells in 365 daysOK
  • CapitalComparable payout data unavailableNote

Business

CPS TECHNOLOGIES CORP/DE/: our business model of providing advanced material solutions to a portfolio of high growth markets provides CPS with the opportunity for sustained growth and a diversified customer base.

Leadership changes

From CPS TECHNOLOGIES CORP/DE/'s own filings, the day they're filed.

  • I. James Cavoli · Directors · appointmenteff. 2024-12-03
  • Thomas Culligan · Directors · departureeff. 2024-06-03
  • Brian Mackey · President · appointmenteff. 2023-08-14

Latest filings

  • 8-K · Company announcement2026-08-24
  • 10-Q · Quarterly report2026-08-11
  • 8-K · Company announcement2026-08-06
  • 8-K · Company announcement2026-06-01
  • 8-K · Company announcement2026-05-08
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about CPS TECHNOLOGIES CORP/DE/, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.